Articles by Disease (Non Hodgkin's Lymphoma)

CypA: A Potential Target of Tumor Radiotherapy and/or Chemotherapy

Journal: Current Medicinal Chemistry
Volume: 28
Page: 3787-3802
Author(s): Man-Yu Chu, He-Cheng Huang, En-Ming Li and Li-Yan Xu*

Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical Research

Journal: Current Medicinal Chemistry
Volume: 28
Page: 3271-3286
Author(s): Cristina Martín-Sabroso, Ana Isabel Fraguas-Sánchez, Rafaela Raposo-González and Ana Isabel Torres-Suárez*

A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century

Journal: Current Medicinal Chemistry
Volume: 28
Page: 2657-2696
Author(s): Rajesh Kumar, Seetha Harilal, Simone Carradori* and Bijo Mathew*

A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma

Journal: Current Topics in Medicinal Chemistry
Volume: 21
Page: 790-818
Author(s): Shahrukh Qureshi, Ravina Khandelwal, Maddala Madhavi, Naveesha Khurana, Neha Gupta, Saurav K. Choudhary, Revathy A. Suresh, Lima Hazarika, Chillamcherla D. Srija, Khushboo Sharma, Mali R. Hindala, Tajamul Hussain, Anuraj Nayarisseri* and Sanjeev K. Singh*

Immunological Mechanism and Clinical Application of PAMP Adjuvants

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 16
Page: 30-43
Author(s): Yu Yan, Dan Yao and Xiaoyu Li*

Immunoconjugates for Cancer Targeting: A Review of Antibody-Drug Conjugates and Antibody-Functionalized Nanoparticles

Journal: Current Medicinal Chemistry
Volume: 28
Page: 2485-2520
Author(s): Raquel Petrilli, Daniel Pascoalino Pinheiro, Fátima de Cássia Evangelista de Oliveira, Gabriela Fávero Galvão, Lana Grasiela Alves Marques, Renata Fonseca Vianna Lopez, Claudia Pessoa and Josimar O. Eloy*

Articles by Disease (Non Hodgkin's Lymphoma)

CypA: A Potential Target of Tumor Radiotherapy and/or Chemotherapy

Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical Research

A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century

A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma

Immunological Mechanism and Clinical Application of PAMP Adjuvants

Immunoconjugates for Cancer Targeting: A Review of Antibody-Drug Conjugates and Antibody-Functionalized Nanoparticles

Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors

Recent Advances in the Design and Development of Anticancer Molecules based on PROTAC Technology

Glycyrrhizic Acid Derivatives as New Antiviral and Immune Modulating Agents

MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy